Depression is a common but serious mood disorder that can affect how a person feels, thinks, and handles their daily activities. It can be a confusing disorder to understand because there are ...
Drug maker Granules India on Friday said it has received approval from the US health regulator to market a generic medication to treat major depressive disorder. The company has received approval from ...
What we're seeing is that this drug has a fairly benign safety profile.” Supernus is aiming to share data from the phase 2b trial, which is testing SPN-820 in treatment-resistant depression (TRD ...
The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal affective disorder. Granules said it has now a total of 67 ANDA approvals from the ...
Treatment-resistant depression (TRD) occurs when major depressive disorder (MDD) treatment does not work. There is no official definition or set criteria for TRD, but the measure often used is an ...